Literature DB >> 14963129

Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Grant Trobridge1, David W Russell.   

Abstract

Retroviral vectors based on foamy viruses (FV) are efficient gene delivery vehicles for therapeutic and research applications. While previous studies have shown that FV vectors transduce quiescent cell cultures more efficiently than oncoviral vectors, their specific cell cycle requirements have not been determined. Here we compare the transduction frequencies of FV vectors with those of onco- and lentiviral vectors in nondividing and dividing normal human fibroblasts by several methods. FV vectors transduced serum-deprived fibroblast cultures more efficiently than oncoretroviral vectors and at rates comparable to those of lentiviral vectors. However, in these cultures FV vectors only transduced a subpopulation of proliferating cells, as determined by bromodeoxyuridine staining for DNA synthesis. In contrast to lentiviral vectors, FV vectors were unable to transduce human fibroblasts arrested by aphidicolin (G(1)/S phase) or gamma-irradiation (G(2) phase), and a partial cell cycle that included mitosis but not DNA synthesis was required. We could not determine if mitosis facilitated nuclear entry of FV vectors, since cell-free vector preparations contained long terminal repeat circles, precluding their use as nuclear markers. In contrast to oncoviral vectors, both FV and lentiviral vectors efficiently transduced G(0) fibroblasts that were later stimulated to divide. In the case of FV vectors, this was due to the persistence of a stable transduction intermediate in quiescent cells. Our findings support the use of FV vectors as a safe and effective alternative to lentiviral vectors for ex vivo transduction of stem cells that are quiescent during culture but divide following transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963129      PMCID: PMC369213          DOI: 10.1128/jvi.78.5.2327-2335.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA.

Authors:  H E Varmus; T Padgett; S Heasley; G Simon; J M Bishop
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

2.  Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.

Authors:  W A O'Brien; A Namazi; H Kalhor; S H Mao; J A Zack; I S Chen
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses.

Authors:  E F Fritsch; H M Temin
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

4.  Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions.

Authors:  R A Katz; C A Omer; J H Weis; S A Mitsialis; A J Faras; R V Guntaka
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Antigenic relationship of human foamy virus to the simian foamy viruses.

Authors:  G J Nemo; P W Brown; C J Gibbs; D C Gajdusek
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 6.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Helper-free foamy virus vectors.

Authors:  G D Trobridge; D W Russell
Journal:  Hum Gene Ther       Date:  1998-11-20       Impact factor: 5.695

8.  Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements.

Authors:  R Swanstrom; W J DeLorbe; J M Bishop; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

10.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  48 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 3.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

4.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Foamy virus vector integration sites in normal human cells.

Authors:  Grant D Trobridge; Daniel G Miller; Michael A Jacobs; James M Allen; Hans-Peter Kiem; Rajinder Kaul; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-20       Impact factor: 11.205

Review 6.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

Review 7.  Retroviral vector interactions with hematopoietic cells.

Authors:  Elizabeth M Everson; Grant D Trobridge
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

8.  Dual transgene expression by foamy virus vectors carrying an endogenous bidirectional promoter.

Authors:  A Andrianaki; E K Siapati; R K Hirata; D W Russell; G Vassilopoulos
Journal:  Gene Ther       Date:  2009-11-12       Impact factor: 5.250

9.  Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.

Authors:  Thomas R Bauer; Laura M Tuschong; Katherine R Calvo; Heather R Shive; Tanya H Burkholder; Eleanor K Karlsson; Robert R West; David W Russell; Dennis D Hickstein
Journal:  Mol Ther       Date:  2013-03-26       Impact factor: 11.454

10.  Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.

Authors:  Thomas R Bauer; James M Allen; Mehreen Hai; Laura M Tuschong; Iram F Khan; Erik M Olson; Rima L Adler; Tanya H Burkholder; Yu-Chen Gu; David W Russell; Dennis D Hickstein
Journal:  Nat Med       Date:  2007-12-23       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.